108 related articles for article (PubMed ID: 7597622)
1. [Rapidly alternating radiochemotherapy in head and neck carcinomas].
Becker A
Strahlenther Onkol; 1995 Jun; 171(6):359-60. PubMed ID: 7597622
[No Abstract] [Full Text] [Related]
2. [Combination cisplatin, 5-FU and low-dose radiotherapy in recurrent carcinomas of the head and neck].
Bolla M; Borgel J; Junien-Lavillauroy ; Sefi A; Guenons A; Lebeau J; Kolodie H; Vincent F
Bull Cancer; 1986; 73(5):542-4. PubMed ID: 3779135
[No Abstract] [Full Text] [Related]
3. [Biological and clinical prerequisites of radiochemotherapy in neoplasms of the cervicofacial area].
Tucci E; Capuano A; Pirtoli L; Bonucci I
Minerva Stomatol; 1987 Nov; 36(11):871-5. PubMed ID: 3323873
[No Abstract] [Full Text] [Related]
4. [Head and neck: concurrent chemoradiotherapy].
Higaki Y; Tomita Y
Gan To Kagaku Ryoho; 2007 Jul; 34(7):1031-3. PubMed ID: 17682303
[No Abstract] [Full Text] [Related]
5. Concomitant chemoradiotherapy for advanced head and neck cancer.
Lin JC; Jan JS; Hsu CY
Jpn J Clin Oncol; 1994 Apr; 24(2):94-100. PubMed ID: 8158863
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of syncope in head and neck cancer with induction chemotherapy.
Choi YM; Mafee MF; Feldman LE
J Clin Oncol; 2006 Nov; 24(33):5332-3. PubMed ID: 17114669
[No Abstract] [Full Text] [Related]
7. Paclitaxel, cisplatin, 5-fluorouracil and radiotherapy in the management of advanced squamous cell carcinoma of the head and neck: a phase II trial.
Merlano M; Russi EG; Numico G; Colantonio I; Garrone O; Pelissero A; Granetto C; Gasco M; Di Costanzo G; Heouaine A; Vigna Taglianti R; Cipolat M
Radiother Oncol; 2005 May; 75(2):193-6. PubMed ID: 16086909
[TBL] [Abstract][Full Text] [Related]
8. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
Kuhnt T; Becker A; Pigorsch S; Pelz T; Bloching M; Passmann M; Lotterer E; Hänsgen G; Dunst J
Strahlenther Onkol; 2003 Oct; 179(10):673-81. PubMed ID: 14566475
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.
Psyrri A; Kwong M; DiStasio S; Lekakis L; Kassar M; Sasaki C; Wilson LD; Haffty BG; Son YH; Ross DA; Weinberger PM; Chung GG; Zelterman D; Burtness BA; Cooper DL
J Clin Oncol; 2004 Aug; 22(15):3061-9. PubMed ID: 15284256
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin combinations in the treatment of head and neck cancer.
al-Sarraf M
Semin Oncol; 1994 Oct; 21(5 Suppl 12):28-34. PubMed ID: 7992064
[TBL] [Abstract][Full Text] [Related]
11. Radiochemotherapy with Vinblastine, Methotrexate, and Bleomycin in the treatment of verrucous carcinoma of the head and neck.
Strojan P; Soba E; Budihna M; Auersperg M
J Surg Oncol; 2005 Dec; 92(4):278-83. PubMed ID: 16299796
[TBL] [Abstract][Full Text] [Related]
12. The role of chemotherapy in the treatment of head and neck cancer.
Inuyama Y; Fukuda S; Furuta Y; Yagi K; Nagahashi T; Chida E; Shirato H; Fujii M; Kanzaki J
Gan To Kagaku Ryoho; 1997 May; 24 Suppl 1():52-9. PubMed ID: 9210888
[No Abstract] [Full Text] [Related]
13. [Chemotherapy of head and neck cancer].
Kohno N; Nakazawa E; Kusunoki M; Nishiya M
Gan To Kagaku Ryoho; 1996 Feb; 23(3):277-82. PubMed ID: 8712819
[TBL] [Abstract][Full Text] [Related]
14. [Role of neoadjuvant chemotherapy for management of resectable head and neck cancer].
Horiuchi M; Tamura Y; Miyake H
Gan To Kagaku Ryoho; 1994 Mar; 21(4):417-24. PubMed ID: 8129381
[TBL] [Abstract][Full Text] [Related]
15. [Biological evaluation of chemo-radiotherapy combined with cisplatin].
Sasaki T; Miura M
Gan No Rinsho; 1990 Oct; 36(13):2234-43. PubMed ID: 2250343
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.
Chang PM; Chen PM; Chu PY; Wang LW; Tai SK; Tsai TL; Huang JL; Wang YF; Chang SY; Yang MH
Cancer Chemother Pharmacol; 2008 Dec; 63(1):9-17. PubMed ID: 18343925
[TBL] [Abstract][Full Text] [Related]
17. A phase I/II study of paclitaxel plus cisplatin as first-line therapy for head and neck cancers: preliminary results.
Hitt R; Hornedo J; Colomer R; Mendiola C; Brandariz A; Sevilla E; Alvarez-Vicent J; Cortés-Funes H
Semin Oncol; 1995 Dec; 22(6 Suppl 15):50-4. PubMed ID: 8643971
[TBL] [Abstract][Full Text] [Related]
18. Chemoradiotherapy as an alternative to radiotherapy alone in fast proliferating head and neck squamous cell carcinomas.
Corvó R; Giaretti W; Sanguineti G; Geido E; Bacigalupo A; Orecchia R; Benasso M; Numico GM; Merlano M; Margarino G; Vitale V
Clin Cancer Res; 1997 Nov; 3(11):1993-7. PubMed ID: 9815589
[TBL] [Abstract][Full Text] [Related]
19. [Head and neck: intra-arterial chemotherapy and combined radiotherapy].
Homma A
Gan To Kagaku Ryoho; 2007 Jul; 34(7):1027-30. PubMed ID: 17682302
[No Abstract] [Full Text] [Related]
20. [Attempts to improve organ preservation in patients with squamous cell carcinoma of the head and neck].
Taguchi T; Tsukuda M
Gan To Kagaku Ryoho; 2005 Dec; 32(13):2030-4. PubMed ID: 16352924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
